Autor: |
Pauline Mulette, Bruno Ravoninjatovo, Camille Guguen, Coralie Barbe, Julien Ancel, Sandra Dury, Antoine Dumazet, Dominique Perdu, Jeanne-Marie Perotin, Thomas Guillard, François Lebargy, Gaëtan Deslee, Claire Launois |
Jazyk: |
angličtina |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-10 (2021) |
Druh dokumentu: |
article |
ISSN: |
1471-2466 |
DOI: |
10.1186/s12890-021-01473-y |
Popis: |
Abstract Background While sleep disruption is a common complaint among children with cystic fibrosis (CF), only a few studies have investigated insomnia in adults. The aim of this study was to identify factors associated with insomnia in clinically stable adult CF patients. Methods Twenty-eight CF patients (18M/10F), with a median age of 27 (22–34) (median (interquartile range) years and a median of forced expiratory volume in one second of 72 (39–93) % predicted completed questionnaires on insomnia (Insomnia Severity Index, ISI), sleep quality (PSQI), daytime sleepiness (Epworth), restless legs syndrome (IRLS), pain (NRS), anxiety/depression (HAD) and quality of life (CFQ-R 14+). Respiratory assessment data, including symptoms, sputum analysis, arterial blood gases, 6-min walking test, pulmonary function tests and polysomnographic variables, were also analyzed. Results Forty-three percent of patients were insomniac (ISI > 7). Compared with non-insomniac patients (ISI ≤ 7), insomniac patients had more severely impaired quality of life and a higher HAD score: median anxiety score of 9 (8–11) vs 4 (3–6) (p |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|